Evaluation of Commercially Available HPV Panels with the Alinity m HR HPV Investigational Use Only (IUO) Assay

被引：0
|
作者：
Kostera, J. [1 ]
Wink, L. [2 ]
New, D. [2 ]
Gang, T. [2 ]
Pitts, E. [2 ]
Lucic, D. [1 ]
Patel, A. [2 ]
机构：
[1] Abbott Mol, Des Plaines, IL USA
[2] PATHAI, Memphis, TN USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ID069
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 27 条
  • [1] The Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed for Management of Patients in Cervical Cancer Screening Programs
    Garcia, E. Herrero
    Lucic, D.
    Nelson, K.
    Cullum, R.
    Lucic, D.
    Kostera, J.
    Huang, S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S58 - S58
  • [2] Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed to Meet US Guidelines for Managing Patients in Cervical Cancer Screening Programs
    Kostera, J.
    Cullum, R.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (02) : S639 - S639
  • [3] Clinical Performance Characteristics of the Alinity m HR HPV (IUO) Assay Compared to COBAS and Aptima HPV Assays
    Kostera, J.
    Wink, L.
    New, D.
    Gang, T.
    Pitts, E.
    Lucic, D.
    Patel, A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S59 - S59
  • [4] Alinity m HR HPV (IUO) Assay: Designed for Evolving Cervical Cancer Screening Programs
    Garcia, E. Herrero
    Lucic, D.
    Nelson, K.
    Cullum, R.
    Lucic, D.
    Kostera, J.
    Huang, S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S58 - S58
  • [5] Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
    Dhillon, Sharonjit K.
    Valencak, Anja Ostrbenk
    Xu, Lan
    Poljak, Mario
    Arbyn, Marc
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (06)
  • [6] Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott)
    Node, Juliette
    Dor, Fanny
    Puget, Line
    Ramanah, Rajeev
    Cot, Sophie
    Bibeau, Frederic
    Di Domizio, Nolwen
    Pretet, Jean-Luc
    Lepiller, Quentin
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [7] Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines
    Mouna, Lina
    Pallier, Coralie
    Deback, Claire
    Proust, Stephanie
    Hottelet, Corinne
    Prevot, Sophie
    Roque-Afonso, Anne-Marie
    [J]. JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (04):
  • [8] Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings
    Valencak, Anja Ostrbenk
    Sterbenc, Anja
    Seme, Katja
    Poljak, Mario
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (01)
  • [9] Analytical performance of the Investigational Use Only Cervista™ HPV HR test as determined by a multi-center study
    Day, Stephen P.
    Hudson, Angela
    Mast, Andrea
    Sander, Tamara
    Curtis, Michelle
    Olson, Sarah
    Chehak, LuAnne
    Quigley, Neil
    Ledford, Joellen
    Yen-Lieberman, Belinda
    Kohn, Debra
    Quigley, Denise I.
    Olson, Marilyn
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2009, 45 : S63 - S72
  • [10] Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting
    Valencak, Anja Ostrbenk
    Bertram, Alexander
    Groning, Arndt
    Poljak, Mario
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2021, 140
123